Session 5: Different reimbursement strategies of anti-CGRP monoclonal antibodies in Nordic countries – a clinical or political decision?

Mattias Linde

Professor of Neurology, Department of Neuroscience, NTNU, Norway, Director of Tjörn Headache Clinic, Sweden

Download presentation